Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial
Top Cited Papers
Open Access
- 9 December 2009
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 375 (9709) , 123-131
- https://doi.org/10.1016/s0140-6736(09)62067-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- 5-Year Survival of Patients with AIDS Receiving Antiretroviral Therapy in HaitiNew England Journal of Medicine, 2009
- Five-Year Outcomes of the China National Free Antiretroviral Treatment ProgramAnnals of Internal Medicine, 2009
- Misclassification of First‐Line Antiretroviral Treatment Failure Based on Immunological Monitoring of HIV Infection in Resource‐Limited SettingsClinical Infectious Diseases, 2009
- The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapyAIDS, 2009
- Fixed duration interruptions are inferior to continuous treatment in African adults starting therapy with CD4 cell counts < 200 cells/μlAIDS, 2008
- The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settingsThe Lancet, 2006
- Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in AfricaAIDS, 2006
- Interim proposal for a WHO Staging System for HIV infection and Disease.1990
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976